Skip to main content


Welcome on our new webpage!

The Multiplicom website has moved! Since we are part of Agilent Technologies, we have found a place for our Next-Generation Sequencing solutions (NGS) on the website. Don’t worry, we are still guiding you towards better results every step of the way, together with Agilent. You can find all your trusted links on the following new Agilent pages:

Testkits & Reporters
Human Offerings
MASTR reporter
Onco Offerings
Clarigo reporter
Prenatal Offerings
Continuous Support
Proof of Principle
Workshops & Training
Expert Service
Enabling Services
Customer Downloads
Frequently Asked Questions
Guiding you towards better results. Every step of the way.

We have been a strong and reliable player in molecular diagnostics for many years. All our products and solutions incorporate the latest medical findings on human genetics, oncology and prenatal testing and are developed and manufactured in compliance with the most stringent international quality standards.

We provide your laboratory with a broad range of molecular NGS solutions, which guide your laboratory towards the more reliable results. Our ready-to-use kits analyze the genes that matter in a simple, efficient and reliable manner. Our Reporter software ensures correct analysis and enables quality control, from sample to final result. Our Facility lab and Expert customer support team help you to set up our tests and secure your results in every step of the way. Click here for our product range.

MASTR Technology

Recent advances in various areas of clinical medicine, diagnostics and genetic testing have created a significant opportunity for the development of high value genetic tests to enable the practice of personalized medicine. The availability of affordable Next-Generation Sequencing systems provides the foundation on which PCR based technologies can be applied to address a wide range of unmet needs.

Click here for more information on our NGS Technology.

Quality standards for Next-Generation Sequencing solutions

Our MASTR technology has been developed and proven to obtain a high level of reliability. We aim to register our major products under the CE-IVD directives and maintain an ISO13485 quality standard. Click here for more information on our quality standards


SureMASTR: Rebranding and removal of GeneScan reagents

Agilent Technologies is rebranding the MASTR assays! As of the 2nd of November, you will see that some of your familiar MASTR solutions will be rebranded to a new name: SureMASTR. Furthermore, the drMID kits (For Research Use Only. Not for use in diagnostic procedures) will be reconfigured. Read More

Clarigo update: Get even more accurate NIPT results!

Clarigo has been updated! Clarigo is an innovative non-invasive prenatal test (NIPT) that analyzes cell-free fetal DNA obtained from blood of the mother. This simple, robust and highly reliable test screens for the aneuploidy status of chromosomes 21, 18, and 13 as early as 8 weeks into the pregnancy. Read More

View all news updates


29 January – 1 February 2019

Clarigo workshop January

23-25 January

SureMASTR workshop January

19-22 March 2019

Clarigo workshop March

13-15 March 2019

SureMASTR workshop March

14-17 May 2019

Clarigo workshop June

8-10 May 2019

SureMASTR workshop May

View all events

Contact us

If you have any other questions, do not hesitate to contact us:


Europe & other countries: